MINNEAPOLIS, Oct. 20 /PRNewswire-FirstCall/ — Uroplasty, Inc.
(Nasdaq:
UPI) announced today that it will release financial results for
the second quarter ended September 30, 2010, at the market close on
Wednesday, October 27, 2010. The Company will host a
conference call to discuss these results on Wednesday, October 27,
2010 at 3:30 p.m. Central Time. David Kaysen, President and
Chief Executive Officer, and Medi Jiwani, Vice President, Chief
Financial Officer and Treasurer, will host the call.
Individuals wishing to participate in the conference call
should dial 877-941-6012. An audio replay will be available
for 30 days following the call at 800-406-7325 (domestic) and
303-590-3030 (international), with the passcode 4374726#.
About Uroplasty, Inc.Uroplasty, Inc., headquartered in
Minnetonka, Minnesota, with wholly-owned subsidiaries in The
Netherlands and the United Kingdom, is a medical device company
that develops, manufactures and markets innovative proprietary
products for the treatment of voiding dysfunctions. Our focus is
the continued commercialization of our Urgent PC system, which we
believe is the only FDA-approved minimally invasive nerve
stimulation device designed for office-based treatment of urinary
urgency, urinary frequency and urge incontinence – symptoms
often associated with overactive bladder.
We also offer Macroplastique Implants, an injectable urethral
bulking agent for the treatment of adult female stress urinary
incontinence primarily due to intrinsic sphincter deficiency. For
more information on the company and its products, please visit
Uroplasty, Inc. at www.uroplasty.com. For Further
Information:Uroplasty, Inc.
David Kaysen, President and CEO, or
Medi Jiwani, Vice President, CFO, Treasurer
952.426.6140 EVC Group
Doug Sherk (Investors),
‘/>”/>
SOURCE
